Pharmacological Treatment of Acute Coronary Syndromes

This book updates clinicians on the most recent data regarding the medical management of patients of acute coronary syndrome (ACS), providing useful information and expert opinion on the large trials, international guidelines, and clinical practice. It reinforces the need for rapid intervention with...

Πλήρης περιγραφή

Λεπτομέρειες βιβλιογραφικής εγγραφής
Συγγραφή απο Οργανισμό/Αρχή: SpringerLink (Online service)
Άλλοι συγγραφείς: Avanzas, Pablo (Επιμελητής έκδοσης), Clemmensen, Peter (Επιμελητής έκδοσης)
Μορφή: Ηλεκτρονική πηγή Ηλ. βιβλίο
Γλώσσα:English
Έκδοση: London : Springer London : Imprint: Springer, 2014.
Σειρά:Current Cardiovascular Therapy
Θέματα:
Διαθέσιμο Online:Full Text via HEAL-Link
LEADER 03264nam a22004935i 4500
001 978-1-4471-5424-2
003 DE-He213
005 20151103125802.0
007 cr nn 008mamaa
008 131004s2014 xxk| s |||| 0|eng d
020 |a 9781447154242  |9 978-1-4471-5424-2 
024 7 |a 10.1007/978-1-4471-5424-2  |2 doi 
040 |d GrThAP 
050 4 |a RC681-688.2 
072 7 |a MJD  |2 bicssc 
072 7 |a MED010000  |2 bisacsh 
082 0 4 |a 616.12  |2 23 
245 1 0 |a Pharmacological Treatment of Acute Coronary Syndromes  |h [electronic resource] /  |c edited by Pablo Avanzas, Peter Clemmensen. 
264 1 |a London :  |b Springer London :  |b Imprint: Springer,  |c 2014. 
300 |a XVI, 245 p. 24 illus., 12 illus. in color.  |b online resource. 
336 |a text  |b txt  |2 rdacontent 
337 |a computer  |b c  |2 rdamedia 
338 |a online resource  |b cr  |2 rdacarrier 
347 |a text file  |b PDF  |2 rda 
490 1 |a Current Cardiovascular Therapy 
505 0 |a Foreword -- Preface -- Anti-ischemic Therapy -- Antiaggregant Therapy: New potent P2Y12 inhibitors -- Anticoagulation Therapy: Heparins and Factor Xa inhibitors -- Secondary prevention in ACS The role of novel oral anticoagulants -- American vs European guidelines -- Critical appraisal -- Triple therapy: Risky but sometimes necessary -- Management of bleeding complications. 
520 |a This book updates clinicians on the most recent data regarding the medical management of patients of acute coronary syndrome (ACS), providing useful information and expert opinion on the large trials, international guidelines, and clinical practice. It reinforces the need for rapid intervention with pharmacologic therapies to treat and prevent coronary thromboembolism, and to prepare the patient for revascularization procedures, especially percutaneous coronary intervention. Pharmacological Treatment of Acute Coronary Syndromes describes conventional treatment – including anti-ischemic, antiplatelet and anticoagulant therapy – and discusses the clinical use of newer treatment options: the potent new P2Y12 platelet receptor inhibitors with the recently recommended ticagrelor and prasugrel, and new oral anticoagulant agents showing promise for acute management and secondary prevention in ACS. Triple therapy, while not initiated in the acute setting, may impact on future surgical and medical emergencies and their management. Also covered are the various recommendations for each of the antiplatelet and anticoagulant agents in terms of patient selection, pretreatment and timing of therapy, making this book an essential read for a wide range of health professionals. 
650 0 |a Pharmacy. 
650 0 |a Medicine. 
650 0 |a Cardiology. 
650 0 |a Pharmacotherapy. 
650 1 4 |a Medicine & Public Health. 
650 2 4 |a Cardiology. 
650 2 4 |a Pharmacy. 
650 2 4 |a Pharmacotherapy. 
700 1 |a Avanzas, Pablo.  |e editor. 
700 1 |a Clemmensen, Peter.  |e editor. 
710 2 |a SpringerLink (Online service) 
773 0 |t Springer eBooks 
776 0 8 |i Printed edition:  |z 9781447154235 
830 0 |a Current Cardiovascular Therapy 
856 4 0 |u http://dx.doi.org/10.1007/978-1-4471-5424-2  |z Full Text via HEAL-Link 
912 |a ZDB-2-SME 
950 |a Medicine (Springer-11650)